Artiva Biotherapeutics, Inc.'s total assets for Q1 2025 were $191.26M, a decrease of -8.74% from the previous quarter. ARTV total liabilities were $22.48M for the fiscal quarter, a -2.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.